Kwangdong Phar Market Cap ($210.34 Million)
Market Cap & Net Worth: Kwangdong Phar (009290)
Kwangdong Phar market cap. Kwangdong Phar (KO:009290) has a market capitalization of $210.34 Million (₩310.38 Billion) as of November 4, 2026. Listed on the KO stock exchange, this Korea-based company holds position #16131 globally and #575 in its home market, demonstrating a -3.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kwangdong Phar's stock price ₩6250.00 by its total outstanding shares 49660974 (49.66 Million). Also see how efficiently does Kwangdong Phar generate cash for how efficiently the company converts equity into cash flow.
Kwangdong Phar Market Cap History (2015–2026)
Kwangdong Phar market cap history from 2015 to 2026. Data shows change from $340.87 Million to $210.34 Million (-5.02% CAGR). Check Kwangdong Phar stock price for real-time trading data and today's change.
Kwangdong Phar Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kwangdong Phar's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Kwangdong Phar (009290) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Kwangdong Phar's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Kwangdong Phar's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $262.91 Million | $1.06 Trillion | $28.06 Billion | 0.00x | 0.01x |
| 2017 | $272.42 Million | $1.14 Trillion | $23.20 Billion | 0.00x | 0.01x |
| 2018 | $215.86 Million | $1.18 Trillion | $22.35 Billion | 0.00x | 0.01x |
| 2019 | $212.13 Million | $1.24 Trillion | $23.06 Billion | 0.00x | 0.01x |
| 2020 | $330.28 Million | $1.24 Trillion | $45.37 Billion | 0.00x | 0.01x |
| 2021 | $242.64 Million | $1.34 Trillion | $24.02 Billion | 0.00x | 0.01x |
| 2022 | $197.88 Million | $1.43 Trillion | $24.17 Billion | 0.00x | 0.01x |
| 2023 | $250.05 Million | $1.51 Trillion | $36.97 Billion | 0.00x | 0.01x |
| 2024 | $183.08 Million | $1.64 Trillion | $40.48 Billion | 0.00x | 0.00x |
| 2025 | $197.22 Million | $1.66 Trillion | $20.97 Billion | 0.00x | 0.01x |
Competitor Companies of 009290 by Market Capitalization
Companies near Kwangdong Phar in the global market cap rankings as of November 4, 2026. Also see Kwangdong Phar balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Kwangdong Phar by market ranking:
- Nestlé S.A (F:NESM): Ranked #88 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #102 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #542 globally with a market cap of $49.71 Billion USD ( €42.52 Billion EUR).
- Danone SA (F:BSND): Ranked #674 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Nestlé S.A | F:NESM | $224.33 Billion | €92.00 |
| #102 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF84.41 |
| #542 | Danone SA | PA:BN | $49.71 Billion | €66.02 |
| #674 | Danone SA | F:BSND | $39.61 Billion | €13.00 |
Market Capitalization of Kwangdong Phar (2015–2026)
Market capitalization of Kwangdong Phar from 2015 to today. Between 2015 and today, Kwangdong Phar's market cap moved from $340.87 Million to $ 210.34 Million, with a yearly change of -5.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩210.34 Million | +6.66% |
| 2025 | ₩197.22 Million | +7.72% |
| 2024 | ₩183.08 Million | -26.78% |
| 2023 | ₩250.05 Million | +26.37% |
| 2022 | ₩197.88 Million | -18.45% |
| 2021 | ₩242.64 Million | -26.53% |
| 2020 | ₩330.28 Million | +55.69% |
| 2019 | ₩212.13 Million | -1.72% |
| 2018 | ₩215.86 Million | -20.76% |
| 2017 | ₩272.42 Million | +3.62% |
| 2016 | ₩262.91 Million | -22.87% |
| 2015 | ₩340.87 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Kwangdong Phar was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $210.34 Million USD |
| MoneyControl | $210.34 Million USD |
| MarketWatch | $210.34 Million USD |
| marketcap.company | $210.34 Million USD |
| Reuters | $210.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Kwangdong Phar
Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti… Read more